• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

归因于高低密度脂蛋白胆固醇的缺血性心脏病死亡率的动态趋势:具有预测能力的联合分析和年龄-时期-队列分析。

Dynamic trends of ischemic heart disease mortality attributable to high low-density lipoprotein cholesterol: a joinpoint analysis and age-period-cohort analysis with predictions.

机构信息

Department of Cardiology, Shanxi Provincial People's Hospital, Fifth Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030012, China.

Department of Cardiology, The First People's Hospital of Jinzhong, Jinzhong, 030602, China.

出版信息

Lipids Health Dis. 2024 Sep 11;23(1):292. doi: 10.1186/s12944-024-02274-y.

DOI:10.1186/s12944-024-02274-y
PMID:39261844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11389117/
Abstract

AIMS

The purpose of this study was to analyze the dynamic trends of ischemic heart disease (IHD) mortality attributable to high low-density lipoprotein cholesterol (LDL-C).

METHODS

Data on IHD mortality attributable to high LDL-C from 1990 to 2021 were extracted from the global disease burden database. Joinpoint software was used to estimate the average annual percentage change (AAPC) in the age-standardized mortality rate (ASMR). An age‒period‒cohort model was used to analyze the impacts of age, period, and cohort on these changes. The Bayesian framework was used to predict IHD mortality attributable to high LDL-C from 2022 to 2040.

RESULTS

The overall ASMR of IHD attributable to high LDL-C decreased from 50. 479 per 100,000 people in 1990 to 32.286 per 100,000 people in 2021, and ASMR of IHD attributable to high LDL-C was higher in males than in females. The longitudinal age curves of the overall IHD mortality attributable to high LDL-C showed a monotonic upward trend, especially after 65 years of age. The period and cohort effect relative risk (RR) values of overall IHD mortality attributable to high LDL-C showed a downward trend. The overall ASMR of IHD attributable to high LDL-C is predicted to show a downward trend, and male IHD mortality attributable to high LDL-C is expected to be higher than that of females.

CONCLUSION

This study revealed a sustained decrease in IHD mortality attributable to high LDL-C over three decades, with a continued decline expected. Despite this, gender disparities persist, with males experiencing higher mortality rates and elderly individuals remaining a vulnerable group.

摘要

目的

本研究旨在分析归因于高低密度脂蛋白胆固醇(LDL-C)的缺血性心脏病(IHD)死亡率的动态趋势。

方法

从全球疾病负担数据库中提取了 1990 年至 2021 年归因于高 LDL-C 的 IHD 死亡率数据。使用 Joinpoint 软件估计年龄标准化死亡率(ASMR)的平均年变化百分比(AAPC)。采用年龄-时期-队列模型分析年龄、时期和队列对这些变化的影响。采用贝叶斯框架预测 2022 年至 2040 年归因于高 LDL-C 的 IHD 死亡率。

结果

归因于高 LDL-C 的 IHD 的总体 ASMR 从 1990 年的每 10 万人 50.479 人下降到 2021 年的每 10 万人 32.286 人,且归因于高 LDL-C 的 IHD 在男性中高于女性。归因于高 LDL-C 的总体 IHD 死亡率的纵向年龄曲线呈单调上升趋势,尤其是在 65 岁以上。归因于高 LDL-C 的总体 IHD 死亡率的时期和队列效应相对风险(RR)值呈下降趋势。归因于高 LDL-C 的总体 IHD 的 ASMR 预计呈下降趋势,且男性归因于高 LDL-C 的 IHD 死亡率预计高于女性。

结论

本研究揭示了 30 多年来归因于高 LDL-C 的 IHD 死亡率持续下降,预计还会继续下降。尽管如此,性别差异仍然存在,男性死亡率较高,老年人仍是弱势群体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a6/11389117/03c88bf75381/12944_2024_2274_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a6/11389117/e0b40534cca7/12944_2024_2274_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a6/11389117/3089d73195db/12944_2024_2274_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a6/11389117/8145a6d7c452/12944_2024_2274_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a6/11389117/03c88bf75381/12944_2024_2274_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a6/11389117/e0b40534cca7/12944_2024_2274_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a6/11389117/3089d73195db/12944_2024_2274_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a6/11389117/8145a6d7c452/12944_2024_2274_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a6/11389117/03c88bf75381/12944_2024_2274_Fig4_HTML.jpg

相似文献

1
Dynamic trends of ischemic heart disease mortality attributable to high low-density lipoprotein cholesterol: a joinpoint analysis and age-period-cohort analysis with predictions.归因于高低密度脂蛋白胆固醇的缺血性心脏病死亡率的动态趋势:具有预测能力的联合分析和年龄-时期-队列分析。
Lipids Health Dis. 2024 Sep 11;23(1):292. doi: 10.1186/s12944-024-02274-y.
2
Time trends in cardiovascular disease mortality attributable to non-optimal temperatures in China: An age-period-cohort analysis using the Global Burden of Disease Study 2019.中国非最适温度导致的心血管疾病死亡率的时间趋势:基于 2019 年全球疾病负担研究的年龄-时期-队列分析
Front Public Health. 2023 Apr 5;10:1075551. doi: 10.3389/fpubh.2022.1075551. eCollection 2022.
3
Time Trends in Ischemic Heart Disease Mortality Attributable to PM Exposure in Southeastern China from 1990 to 2019: An Age-Period-Cohort Analysis.1990 年至 2019 年中国东南部地区因 PM 暴露导致的缺血性心脏病死亡率的时间趋势:一项基于年龄-时期-队列的分析。
Int J Environ Res Public Health. 2023 Jan 5;20(2):973. doi: 10.3390/ijerph20020973.
4
Global and national burden of atherosclerosis from 1990 to 2019: trend analysis based on the Global Burden of Disease Study 2019.全球及各国 1990 年至 2019 年动脉粥样硬化负担变化趋势分析:基于 2019 年全球疾病负担研究结果
Chin Med J (Engl). 2023 Oct 20;136(20):2442-2450. doi: 10.1097/CM9.0000000000002839. Epub 2023 Sep 5.
5
Assessing Global, Regional, and National Time Trends and Associated Risk Factors of the Mortality in Ischemic Heart Disease Through Global Burden of Disease 2019 Study: Population-Based Study.评估 2019 年全球疾病负担研究中全球、区域和国家缺血性心脏病死亡率的时间趋势及其相关危险因素:基于人群的研究。
JMIR Public Health Surveill. 2024 Jan 24;10:e46821. doi: 10.2196/46821.
6
The burden of ischemic heart disease attributable to ambient and household particulate matter pollution, 1990-2019: a global analysis.1990 - 2019年环境和家庭颗粒物污染所致缺血性心脏病负担:一项全球分析
Environ Sci Pollut Res Int. 2023 Nov;30(53):114514-114524. doi: 10.1007/s11356-023-30336-8. Epub 2023 Oct 20.
7
Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study.男性低密度脂蛋白亚组分与缺血性心脏病的长期风险:来自魁北克心血管研究的13年随访数据。
Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):553-9. doi: 10.1161/01.ATV.0000154144.73236.f4. Epub 2004 Dec 23.
8
Ischaemic heart disease mortality in Serbia, 1991-2013; a joinpoint analysis.塞尔维亚 1991-2013 年缺血性心脏病死亡率:联合分析。
Indian J Med Res. 2017 Dec;146(6):746-753. doi: 10.4103/ijmr.IJMR_1935_15.
9
Estimating the changing disease burden attributable to raised low-density lipoprotein cholesterol in South Africa for 2000, 2006 and 2012.估计 2000 年、2006 年和 2012 年南非因低密度脂蛋白胆固醇升高导致的疾病负担变化。
S Afr Med J. 2022 Sep 30;112(8b):607-616. doi: 10.7196/SAMJ.2022.v112i8b.16489.
10
Trends of ischemic heart disease mortality attributable to smoking in the five countries with the highest number of smokers during 1990-2019: an age-period-cohort analysis.1990 - 2019年吸烟者数量最多的五个国家中归因于吸烟的缺血性心脏病死亡率趋势:年龄 - 时期 - 队列分析
Arch Med Sci. 2024 Jan 31;20(1):43-53. doi: 10.5114/aoms/182886. eCollection 2024.

引用本文的文献

1
Global cardiovascular disease burden attributable to particulate matter pollution, 1990-2021: an analysis of the global burden of disease study 2021 and forecast to 2045.1990 - 2021年可归因于颗粒物污染的全球心血管疾病负担:全球疾病负担研究2021分析及到2045年的预测
BMC Cardiovasc Disord. 2025 May 26;25(1):401. doi: 10.1186/s12872-025-04724-6.

本文引用的文献

1
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
2
[2023 ESC Guidelines for the management of acute coronary syndromes].[2023年欧洲心脏病学会急性冠状动脉综合征管理指南]
G Ital Cardiol (Rome). 2024 Feb;25(2 Suppl 2):e1-e112. doi: 10.1714/4191.41785.
3
Significance of fatty liver index to detect prevalent ischemic heart disease: evidence from national health and nutrition examination survey 1999-2016.脂肪肝指数对检测缺血性心脏病患病率的意义:来自1999 - 2016年美国国家健康与营养检查调查的证据
Front Cardiovasc Med. 2023 Oct 12;10:1171754. doi: 10.3389/fcvm.2023.1171754. eCollection 2023.
4
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2023 年 AHA/ACC/ACCP/ASPC/NLA/PCNA 慢性冠状动脉疾病患者管理指南:美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
Circulation. 2023 Aug 29;148(9):e9-e119. doi: 10.1161/CIR.0000000000001168. Epub 2023 Jul 20.
5
Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease: A Factorial Mendelian Randomization Study.联合遗传抑制 PCSK9 和 CETP 与冠状动脉疾病的关联:一项析因 Mendelian 随机化研究。
JAMA Cardiol. 2022 Sep 1;7(9):955-964. doi: 10.1001/jamacardio.2022.2333.
6
New Therapeutic Approaches in Treatment of Dyslipidaemia-A Narrative Review.血脂异常治疗的新方法——一项叙述性综述
Pharmaceuticals (Basel). 2022 Jul 7;15(7):839. doi: 10.3390/ph15070839.
7
Global Burden Attributable to High Low-Density Lipoprotein-Cholesterol From 1990 to 2019.1990年至2019年全球归因于低密度脂蛋白胆固醇水平过高的疾病负担
Front Cardiovasc Med. 2022 Jun 9;9:903126. doi: 10.3389/fcvm.2022.903126. eCollection 2022.
8
Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease.2019 年全球疾病负担研究表明,代谢危险因素是导致缺血性心脏病负担的主要驱动因素。
Cell Metab. 2021 Oct 5;33(10):1943-1956.e2. doi: 10.1016/j.cmet.2021.08.005. Epub 2021 Sep 2.
9
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.全球心血管疾病负担及危险因素, 1990-2019:来自 GBD 2019 研究的更新。
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
10
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.用于心血管疾病一级和二级预防的前蛋白转化酶枯草溶菌素9单克隆抗体。
Cochrane Database Syst Rev. 2020 Oct 20;10(10):CD011748. doi: 10.1002/14651858.CD011748.pub3.